Dudediligence.

Insulet Corporation

PODDNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$543.9MSep ’24$597.5MDec ’24$569.0MMar ’25$649.1MJun ’25$706.3MSep ’25$783.8MDec ’25$761.7MMar ’26$801.7MJun ’26
Net income, by quarter
$77.5MSep ’24$100.7MDec ’24$35.4MMar ’25$22.5MJun ’25$87.6MSep ’25$101.6MDec ’25$91.1MMar ’26$95.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.10B$1.31B$1.70B$2.07B$2.71B
Gross profit$752.1M$805.6M$1.16B$1.45B$1.94B
Operating income$126.0M$37.6M$220.1M$308.9M$473.8M
Net income$16.8M$4.6M$206.3M$418.3M$247.1M
Operating cash flow−$68.1M$119.0M$145.7M$430.2M$569.3M
Free cash flow−$180.0M−$3.9M$70.1M$305.3M$377.7M
Cash$806.4M$689.8M$704.2M$953.4M$716.1M
Debt$1.27B$1.40B$1.42B$1.38B$949.2M
Shares outstanding69.2M69.5M69.9M70.2M70.4M